Shandong Boan Biotechnology Co (HKSE:06955) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06955 Shandong Boan Biotechnology Co Ltd HKSE:06955
42 GF Score
Price HK$2.93
GF Value HK$16.69
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Shandong Boan Biotechnology Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

HKSE:06955
42GF Score
Shandong Boan Biotechnology Co Ltd HKSE:06955
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shandong Boan Biotechnology Co (HKSE:06955) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Boan Biotechnology Co stock appears to be undervalued. The current stock price of HK$2.93 is trading 82.4% below its estimated GF Value™ of HK$16.69. GuruFocus considers Shandong Boan Biotechnology Co to be Possible Value Trap.

Key valuation signals for HKSE:06955:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: HK$16.69 vs. price of HK$2.93 (82.4% below fair value)
  • GF Score™: 42/100 with 4 warning signs

No single metric tells the full story. See the HKSE:06955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shandong Boan Biotechnology Co Business Description

Address No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN
Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. It is focused on developing, manufacturing, and marketing biologics, with a focus on oncology, autoimmune diseases, ophthalmology, and metabolic diseases. The company's drug discovery activities revolve around multiple platforms: Fully Human Antibody Platform, bsAb/msAb/Probody Platform, and ADC Platform. It has commercialized several products, such as Boyounuo, Boyoubei (denosumab injection 60 mg), Boluojia (denosumab injection 120 mg), Boyouping (dulaglutide injection), and Boyoujing; and is actively engaged in the development of other drugs like BA1104 (nivolumab injection), BA1106, BA1302 (an anti-CD228 ADC), etc. Geographically, the company generates maximum revenue from the Chinese mainland.
42GF Score

Get the complete analysis for HKSE:06955

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.93
Price
HK$16.69
GF Value